Eduard H Panosyan

Title(s)HS Associate Clinical Professor, Pediatrics
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Publisher Correction to: Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma. Pediatr Res. 2023 Aug; 94(2):847. Panosyan WS, Panosyan DE, Koster J, Panosyan EH. PMID: 36932184.
      View in: PubMed   Mentions:    Fields:    
    2. Chronic Myeloid Leukemia in Children and Adolescents. Adv Pediatr. 2023 08; 70(1):145-155. Gotesman M, Raheel S, Panosyan EH. PMID: 37422292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma. Pediatr Res. 2023 08; 94(2):458-461. Panosyan WS, Panosyan DE, Koster J, Panosyan EH. PMID: 36788290.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy. In Vivo. 2022 Jul-Aug; 36(4):1761-1768. Gotesman M, Elgar G, Santiago LH, Alvarez A, Pak Y, Lin HJ, Lasky JL, Panosyan EH. PMID: 35738636; PMCID: PMC9301392.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth. Anticancer Res. 2022 Apr; 42(4):1697-1706. Lasky JL, Bradford KL, Wang Y, Pak Y, Panosyan EH. PMID: 35346988.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    6. Primary Renal Ewing Sarcoma in Children and Young Adults. J Pediatr Hematol Oncol. 2020 11; 42(8):474-481. Bradford K, Nobori A, Johnson B, Allen-Rhoades W, Naik-Mathuria B, Panosyan EH, Gotesman M, Lasky J, Cheng J, Ikeda A, Goldstein J, Singh A, Federman N. PMID: 32282650; PMCID: PMC7554078.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. A Case of Langerhans Cell Histiocytosis With Multifocal, Single-System GI Tract Involvement and Literature Review. J Pediatr Hematol Oncol. 2020 08; 42(6):e491-e493. Gotesman M, Getachew R, Morales S, Zangwill KM, Gershman G, Lee S, Lasky JL, Panosyan EH. PMID: 31764515.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Novel ELANE Gene Mutation in a Newborn with Severe Congenital Neutropenia: Case Report and Literature Review. J Pediatr Genet. 2020 Sep; 9(3):203-206. Jia Y, Yue C, Bradford K, Qing X, Panosyan EH, Gotesman M. PMID: 32714623; PMCID: PMC7375850.
      View in: PubMed   Mentions:
    9. The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma. Exp Mol Pathol. 2019 08; 109:42-50. Jia Y, Lue Y, Swerdloff RS, Lasky JL, Panosyan EH, Dai-Ju J, Wang C. PMID: 31085184; PMCID: PMC6680022.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    10. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. PMID: 30021096.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansCTClinical Trials
    11. Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma. Anticancer Res. 2018 05; 38(5):2627-2634. Sanghez V, Chen M, Li S, Chou TF, Iacovino M, Lin HJ, Lasky JL, Panosyan EH. PMID: 29715082.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    12. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia. Exp Mol Pathol. 2017 12; 103(3):263-266. Qing X, Panosyan E, Yue C, Ji P, Gotesman M, French S, Cai J. PMID: 29155023.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. In search of druggable targets for GBM amino acid metabolism. BMC Cancer. 2017 02 28; 17(1):162. Panosyan EH, Lin HJ, Koster J, Lasky JL. PMID: 28245795; PMCID: PMC5331648.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    14. HLA-DR antigen-positive acute promyelocytic leukemia. Exp Mol Pathol. 2016 Oct; 101(2):197-200. Mendoza AS, Qing X, Dungo M, Lasky J, Panosyan E, Cai J. PMID: 27544027.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids. J Neurooncol. 2016 05; 128(1):57-66. Panosyan EH, Lasky JL, Lin HJ, Lai A, Hai Y, Guo X, Quinn M, Nelson SF, Cloughesy TF, Nghiemphu PL. PMID: 26922345; PMCID: PMC5373108.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    16. Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report. Cancer. 2015 Dec 01; 121(23):4205-11. Ko RH, Jones TL, Radvinsky D, Robison N, Gaynon PS, Panosyan EH, Avramis IA, Avramis VI, Rubin J, Ettinger LJ, Seibel NL, Dhall G. PMID: 26308766; PMCID: PMC4795901.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    17. Clinicocytopathologic correlation in an atypical presentation of lymphadenopathy with review of literature. Am J Clin Pathol. 2015 May; 143(5):749-54. Choi AH, Bolaris M, Nguyen DK, Panosyan EH, Lasky JL, Duane GB. PMID: 25873511.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    18. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res. 2014 May; 12(5):694-702. Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, Lasky JL. PMID: 24505127; PMCID: PMC4020976.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    19. Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res. 2013 May; 33(5):2047-56. Lasky JL, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. PMID: 23645755; PMCID: PMC4018463.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    20. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Mol Cancer Ther. 2011 Oct; 10(10):1818-28. Visnyei K, Onodera H, Damoiseaux R, Saigusa K, Petrosyan S, De Vries D, Ferrari D, Saxe J, Panosyan EH, Masterman-Smith M, Mottahedeh J, Bradley KA, Huang J, Sabatti C, Nakano I, Kornblum HI. PMID: 21859839; PMCID: PMC3191241.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    21. High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA. J Transplant. 2011; 2011:740673. Panosyan EH, Ikeda AK, Chang VY, Laks DR, Reeb CL, Bowles LV, Lasky JL, Moore TB. PMID: 21559259; PMCID: PMC3087896.
      View in: PubMed   Mentions: 5  
    22. Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation. Pediatr Blood Cancer. 2010 Oct; 55(4):644-51. Panosyan EH, Laks DR, Masterman-Smith M, Mottahedeh J, Yong WH, Cloughesy TF, Lazareff JA, Mischel PS, Moore TB, Kornblum HI. PMID: 20589659; PMCID: PMC4017922.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    23. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Res. 2010 Aug 01; 70(15):6128-38. Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, Liu M, Zhang N, Wang S, Angenieux B, Panosyan E, Samuels ER, Park J, Williams D, Konkankit V, Nathanson D, van Dam RM, Phelps ME, Wu H, Liau LM, Mischel PS, Lazareff JA, Kornblum HI, Yong WH, Graeber TG, Tseng HR. PMID: 20631065; PMCID: PMC3163840.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    24. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Clin Cancer Res. 2006 Dec 01; 12(23):6978-84. Avramis IA, Panosyan EH, Dorey F, Holcenberg JS, Avramis VI, Children's Oncology Group. PMID: 17145817.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    25. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet. 2005; 44(4):367-93. Avramis VI, Panosyan EH. PMID: 15828851.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCells
    26. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clin Cancer Res. 2004 Aug 15; 10(16):5335-41. Hawkins DS, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, Panosyan EH, Avramis VI. PMID: 15328169.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    27. Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol. 2004 Apr; 26(4):217-26. Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin J, Nachman J, Ettinger LJ, La M, Steinherz P, Cohen LJ, Siegel SE, Avramis VI, Children's Cancer Group Study CCG-1961. PMID: 15087948.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    28. Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961). In Vivo. 2004 Mar-Apr; 18(2):107-12. Grigoryan RS, Panosyan EH, Seibel NL, Gaynon PS, Avramis IA, Avramis VI. PMID: 15113036.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    29. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Res. 2004 Mar-Apr; 24(2C):1121-5. Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI. PMID: 15154634.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Eduard's Networks
    Concepts (167)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California